The largest database of trusted experimental protocols

13 protocols using hi 14k

1

Standardized Meal Glucose Tolerance

Check if the same lab product or an alternative is used in the 5 most similar protocols
We tested glucose tolerance to a standardized real-life mimicking meal. Participants were instructed orally and in writing to be sedentary (allowed to walk at a leisurely pace) and avoid alcohol in the 24 h preceding the meal test. The participants arrived at 0815 h in the morning after 10 h of overnight fasting, including a temporary discontinuation of medications and tobacco-products. They consumed a standardized meal of 600 kcal (2502 kJ, 48% carbohydrates, 17% protein and 35% fat) within 15 min. The meal consisted of whole grain bread, butter, cheese, jam, orange juice, and either milk or sweetened yoghurt drink [25 (link)].
Blood was sampled in EDTA tubes in the fasting mode and then half-hourly for 150 min. Samples were centrifuged immediately (2110 RCF, 10 min, 18° C). Plasma, frozen in cryo tubes, were kept at -80° C pending analyses of glucose and insulin. Plasma glucose was measured using Biosen C-Line Clinic/GP+ (EKF Diagnostics, Cardiff, UK) and immunoreactive insulin using human insulin-specific RIA kits (HI-14K, Merck Millipore, Merck KGaA, Darmstadt, Germany).
+ Open protocol
+ Expand
2

Comprehensive Metabolic Marker Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Throughout the study period, serum was collected for cortisol, glucose, insulin, glucagon, NPY, leptin, ACTH, and GLP-1. In addition, saliva was collected to measure free cortisol. Analyses were performed according to the manufacturer specifications using radioimmunoassay for Cortisol (MP Biomedical, #06B256440; RRID:AB_2801525), Insulin (EMD Millipore, #HI-14 K; RRID:AB_2801577), Glucagon (EMD Millipore, #GL-32 K; RRID:AB_2757819), Leptin (EMD Millipore, HL-81 K; RRID:AB_2756879) and ACTH (MP Biomedical, #07–106102; RRID:AB_2783719) or ELISA for NPY (Millipore, EZHNPY-25 K; RRID:AB_2909594) and GLP-1 Total and Active (43-GPTHU-E01; RRID:AB_2801400). Glucose was measured at point of care (YSI).
+ Open protocol
+ Expand
3

Plasma Lipid and Glucose Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were centrifuged immediately and kept on ice for the duration of each condition, then frozen at either −80 °C [free fatty acid (FFA) and insulin] or −20 °C (glucose, triglycerides). Plasma levels of insulin were measured with radioimmunoassay kits that utilize the double antibody technique with 125I-labeled hormone and hormone antiserum (Cat. # HI-14K, EMD Millipore Corporation, Billerica MA). Glucose, FFA and triglyceride concentrations were measured using enzymatic colorimetric techniques (FFA: Cat. # 999–34691, 991034891, 993–35191, Wako Pure Chemical Industries, Ltd., Osaka, Japan. Triglycerides: Cat. # SA1023, RX1023; Glucose: Cat. # SA1014, RX1014, Alfa Wassermann Diagnostic Techniques, West Caldwell NJ).
The effects of time, condition, and group, as well as interactions between the above, on the concentration of triglycerides were tested using a mixed-design ANOVA. We then tested the association between caloric intake and baseline triglyceride concentrations at the Sated session in each group by Pearson’s correlation analysis.
+ Open protocol
+ Expand
4

Insulin Secretion Assay in Pancreatic Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
EndoC-βH1 and βH2 cells were seeded onto coated 24 well plates at a density of 300,000 cells/well. The night before experiment, the cells were incubated in 2.8 mmol/L glucose culture medium. Prior to the experiment, the cells were incubated in a modified Krebs-Ringer buffer (KRB) medium consisting of (mmol/L) 138 NaCl, 3.6 KCl, 0.5 MgSO4, 0.5 NaH2PO4, 5 NaHC03, 1.5 CaCl2 and 5 HEPES (adjusted to pH 7.4 with NaOH) and supplemented with 0.2% w/v BSA. The cells were washed with the glucose-free medium, preincubated for 15 min at 1 mmol/L glucose before a 40 min test incubation at either 1, 6 or 20 mmol/L glucose and with added tolbutamide (0.2 mmol/L) or diazoxide (0.5 mmol/L) as indicated. Supernatants (0.3 ml) were taken for determination of insulin release. Cellular insulin content was extracted by acid ethanol treatment. The samples were frozen pending later analysis which was carried out using commercial ELISA (Alpha Laboratories) or radioimmunosassay (HI-14 K, Merck). Insulin secretion is expressed as a percentage of cellular insulin content and fold-increase in secretion as a ratio with basal secretion (1 mmol/L). The somatostatin receptor 2 (SSTR2) antagonist CYN154806 was obtained from TOCRIS (Abingdon, UK).
+ Open protocol
+ Expand
5

Measuring Feeding-Related Hormones in Human Plasma

Check if the same lab product or an alternative is used in the 5 most similar protocols
Sufficient blood samples for processing at all three scans were obtained from n=25 out of the 32 total subjects. Samples were centrifuged immediately and kept on ice for the duration of each session, then frozen at either −80°C (FFA, ghrelin, insulin) or −20°C (glucose, triglycerides). Plasma levels of feeding-related hormones were measured with commercially available materials. Insulin and total ghrelin levels were measured with radioimmunoassay kits that utilize the double antibody technique with 125I-labeled hormone and hormone antiserum (Ghrelin: Cat. # GHRT-89HK; Insulin: Cat. # HI-14K, EMD Millipore Corporation, Billerica MA). Glucose, FFA and triglyceride concentrations were measured using enzymatic colorimetric techniques (FFA: Cat. # 999-34691, 991034891, 993-35191, Wako Pure Chemical Industries, Ltd., Osaka, Japan. Triglycerides: Cat. # SA1023, RX1023; Glucose: Cat. # SA1014, RX1014, Alfa Wassermann Diagnostic Techniques, West Caldwell NJ).
+ Open protocol
+ Expand
6

Insulin Secretion Dynamics by Human Islets

Check if the same lab product or an alternative is used in the 5 most similar protocols
To define the dynamic effects of VCS and TAC on insulin secretion from human islets, we used human islet perifusion studies (7 (link)). We assessed the effects of TAC (10 ng/mL, 30 ng/mL) and VCS (20 ng/mL, 60 ng/mL) on the dynamics of insulin secretion in response to 2 stimuli that are diagnostic of changes in metabolism/signaling or exocytosis. Our standard approach (7 (link), 15-20 (link)) compared the response to 15 mM glucose stimulation and direct depolarization with 30 mM KCl. More specifically, 65 islets per column were perifused (0.4 mL/min) with 3 mM glucose KRB solution as described previously (7 (link)) for 60 minutes to equilibrate the islets to the KRB and flow rate, and then with the indicated condition (as described in corresponding figure legends). First-phase insulin release was defined as the amount of insulin secreted during the first 20 minutes of 15 mM glucose stimulation, while the remaining 40 of stimulation were defined as second-phase. Dimethyl sulfoxide (DMSO), VCS, and TAC were present at the indicated concentrations during the entirety of the perifusion experiment. We repeated this experiment on islets from 17 donors to take into account the significant variability between human islet preparations (11 (link)). Samples were stored at −20 °C and insulin secretion was quantified using human insulin radioimmunoassay kits (Millipore Cat# HI-14K) (21 ).
+ Open protocol
+ Expand
7

Plasma Glucose and Hormone Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose was measured in duplicate by the glucose oxidase method using an automated glucose analyzer (YSI 2300; Yellow Springs Instruments, Yellow Springs, OH, USA). Additional blood samples were collected into tubes on ice containing ethylenediamine tetra-acetate and protease inhibitor cocktail and, for the MMTT test, dipeptidyl peptidase-4 inhibitor (Sigma-Aldrich, St. Louis, MO, USA). Samples were centrifuged at 4°C, separated, and frozen at −80°C for subsequent analysis. Plasma insulin (Millipore Cat# HI-14 K, RRID: AB_2801577) and C-peptide (Millipore Cat# HCP-20 K, RRID: AB_2891151) were assayed in duplicate by double-antibody radioimmunoassay (Millipore, Billerica, MA, USA).
+ Open protocol
+ Expand
8

Plasma Biomarker Measurements in Human Participants

Check if the same lab product or an alternative is used in the 5 most similar protocols
Blood samples were collected
directly into purple K2-EDTA vacutainers (Becton Dickinson)
and placed on ice immediately after collection. Samples were centrifuged
within 10 min of collection at 4 °C and the plasma frozen at
−80 °C in cryotubes. Blood lipids and fasting blood glucose
were examined by photometric assays in the laboratory of SA Pathology
(Adelaide, South Australia, Australia). Serum insulin was measured
by radioimmunoassay (HI-14K, Millipore, MA, USA). Serum nonesterified
fatty acids (NEFA) were measured by enzymatic colorimetric assay (NEFA-HR
(2), Wako Diagnostics, CA, USA). Plasma β-hydroxybutyrate (RANBUT
D-3 Hydroxybutyrate kit; Randox, Antrim, UK) and high-sensitivity
c-reactive protein (HS-CRP) were measured using commercially available
enzymatic kits (Beckman Coulter Inc., CA, USA) on a Beckman AU480
clinical analyzer (Beckman Coulter Inc.). Samples from each participant
were analyzed within the same run to reduce instrument variation,
and these measures were used as some of the variables for the unbiased
correlation analysis.
+ Open protocol
+ Expand
9

Multi-species Insulin Quantification

Check if the same lab product or an alternative is used in the 5 most similar protocols
Guinea pig anti-insulin, rat insulin-plus-proinsulin radioimmunoassay (RIA) that cross-reacts with other species (RI-13K), and human insulin–specific RIA (HI-14K) were from Millipore; ultrasensitive mouse insulin ELISA (80-INSMSU-E01) was from Alpco; “RIA-grade” BSA was from Sigma-Aldrich.
+ Open protocol
+ Expand
10

Measurement of Muscle Protein Synthesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma glucose and insulin concentrations were analyzed using commercially available kits (ref. no. A11A01667, Glucose HK CP, ABX Diagnostics; and ref. no. HI-14 K, Millipore, respectively). Plasma amino acid concentrations were determined by UPLC-MS, as previously described (26 (link)). Plasma l-[ring-13C6]-phenylalanine enrichments were determined by GC-MS (Agilent 7890A GC/5975C MSD; Agilent Technologies), as previously described (26 (link)).
Basal muscle protein synthesis rates were assessed to confirm that protein ingestion increases muscle protein synthesis rates. The single biopsy approach was applied to assess postabsorptive muscle protein synthesis rates without the need to collect an additional muscle biopsy, as previously described (26 (link), 30 (link)).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!